I agree that this site is using cookies. You can find further informations here.
X
Weersink, Rianne A.
61  results:
Search for persons X
?
1

Recommendations for the safe use of direct oral anticoagula..:

Diesveld, Maaike M. E. ; Pijnenburg, Daniëlle W. M. Jacobs- ; Weersink, Rianne A....
European Journal of Clinical Pharmacology.  80 (2024)  6 - p. 797-812 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Changing Prevalence of Medication Use in People with Cirrho..:

Hayward, Kelly L. ; Weersink, Rianne A. ; Bernardes, Christina M....
Drugs - Real World Outcomes.  10 (2023)  4 - p. 605-618 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Collaboration Is Needed to Translate Pharmacology Data Into..:

Weersink, Rianne A. ; Hayward, Kelly L.
Hepatology Communications.  5 (2021)  4 - p. 715-716 , 2021
Link: https://doi.org/10.1002/..
 
?
4

Idiosyncratic drug-induced liver injury in the elderly: an ..:

Weersink, Rianne A. ; Alvarez-Alvarez, Ismael ; Medina-Caliz, I...
Journal of Hepatology.  73 (2020)  - p. S218 , 2020
Link: https://doi.org/10.1016/..
 
?
5

Improving Medication‐Related Outcomes in Chronic Liver Dise..:

Hayward, Kelly L. ; Weersink, Rianne A.
Hepatology Communications.  4 (2020)  11 - p. 1562-1577 , 2020
Link: https://doi.org/10.1002/..
 
?
6

Medication safety in patients with hepatic impairment: A su..:

Weersink, Rianne A. ; Abadier, Marianna ; de Boer, Anthonius..
British Journal of Clinical Pharmacology.  86 (2020)  4 - p. 763-770 , 2020
Link: https://doi.org/10.1111/..
 
?
7

Recommendations for Safe Medication Use in Liver Impairment..:

Borgsteede, Sander D. ; Weersink, Rianne A. ; Geijteman, Eric..
Journal of Pain and Symptom Management.  59 (2020)  3 - p. e6-e8 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Clinical Characteristics and Outcome of Drug‐Induced Liver ..:

Weersink, Rianne A. ; Alvarez‐Alvarez, Ismael ; Medina‐Cáliz, Inmaculada...
Clinical Pharmacology & Therapeutics.  109 (2020)  4 - p. 1147-1158 , 2020
Link: https://doi.org/10.1002/..
 
?
9

Guidance for Safety and Dosing of Medicines in Patients Wit..:

Weersink, Rianne A. ; Drenth, Joost P.H. ; Hunfeld, Nicole G.M..
Hepatology Communications.  3 (2019)  9 - p. 1281-1282 , 2019
Link: https://doi.org/10.1002/..
 
?
10

THU-433-Availability of information in drug labels for appr..:

Weersink, Rianne A. ; Timmermans, Lotte ; Monster-Simons, Margje H....
Journal of Hepatology.  70 (2019)  1 - p. e347-e348 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Safe use of medication in patients with cirrhosis: pharmaco..:

Weersink, Rianne A. ; Burger, David M. ; Hayward, Kelly L....
Expert Opinion on Drug Metabolism & Toxicology.  16 (2019)  1 - p. 45-57 , 2019
Link: https://doi.org/10.1080/..
 
?
12

SAT-137-Adverse drug reactions in patients with cirrhosis: ..:

Weersink, Rianne A. ; Taxis, Katja ; van Puijenbroek, Eugene G..
Journal of Hepatology.  70 (2019)  1 - p. e691 , 2019
Link: https://doi.org/10.1016/..
 
?
13

Evaluation of Information in Summaries of Product Character..:

Weersink, Rianne A. ; Timmermans, Lotte ; Monster-Simons, Margje H....
Frontiers in Pharmacology.  10 (2019)  - p. , 2019
Link: https://doi.org/10.3389/..
 
?
14

Prevalence of Drug Prescriptions and Potential Safety in Pa..:

Weersink, Rianne A. ; Taxis, Katja ; Drenth, Joost P. H....
Drug Safety.  42 (2018)  4 - p. 539-546 , 2018
Link: https://doi.org/10.1007/..
 
?
15

Safe use of proton pump inhibitors in patients with cirrhos..:

Weersink, Rianne A. ; Bouma, Margriet ; Burger, David M....
British Journal of Clinical Pharmacology.  84 (2018)  8 - p. 1806-1820 , 2018
Link: https://doi.org/10.1111/..
 
1-15